Huang Ping, Liu Fen, Zeng Zhenguo, Huang Caixue, Shao Qiang, Xia Liang, Jie Kemin, Qian Kejian
State Drug Clinical Trial Agency, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China. Corresponding author: Qian Kejian, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):300-3. doi: 10.3760/cma.j.issn.2095-4352.2014.05.003.
To observe the effect of transfected microRNA-146a (miR-146a) on expression of interleukin-1 receptor-associated kinase 1 (IRAK-1) and tumor necrosis factor receptor-associated factor 6 (TRAF-6) in alveolar macrophages, and to explore the regulatory mechanism of miR-146a in the inflammatory response of alveolar macrophages.
Alveolar macrophages NR8383 were cultured and divided into two groups: transfected miR-146a mimic group was transfected 50 nmol/L Pre-miR miR-146a precursors and the negative control group was transfected Cy3-labeled Pre-miR negative control. Cells were collected at 24 hours after transfection. The miR-146a and the mRNA expression of IRAK-1 and TRAF-6 were detected by real-time fluorescent quantitation reverse transcription-polymerase chain reaction (RT-qPCR), and the protein expression of IRAK-1 and TRAF-6 was assayed by Western Blot.
Compared with negative control group, the expression of miR-146a was upregulated by (24.55±6.14) fold compared with miR-146a mimic group (t=-9.353, P=0.001). The mRNA expressions of IRAK-1 and TRAF-6 in miR-146a mimic group were upregulated by (1.16±0.10) fold (t=2.701, P=0.054) and (1.19±0.16) fold (t=2.032, P=0.112) , respectively, compared with that of negative control group, but the protein levels of IRAK-1 and TRAF-6 were decreased by 73.0% (t=-9.353, P=0.001) and 64.1% (t=-6.839, P=0.002), respectively .
miR-146a mimic was successfully transfected into the alveolar macrophage NR8383. The overexpression of miR-146a in alveolar macrophages can down-regulate the expression of IRAK-1 and TRAF-6 in protein translation levels, and its mechanism may be related with inhibition of protein translation.
观察转染微小RNA-146a(miR-146a)对肺泡巨噬细胞中白细胞介素-1受体相关激酶1(IRAK-1)和肿瘤坏死因子受体相关因子6(TRAF-6)表达的影响,探讨miR-146a在肺泡巨噬细胞炎症反应中的调控机制。
培养肺泡巨噬细胞NR8383,分为两组:转染miR-146a模拟物组转染50 nmol/L的Pre-miR miR-146a前体,阴性对照组转染Cy3标记的Pre-miR阴性对照。转染后24小时收集细胞。采用实时荧光定量逆转录-聚合酶链反应(RT-qPCR)检测miR-146a以及IRAK-1和TRAF-6的mRNA表达,采用蛋白质印迹法检测IRAK-1和TRAF-6的蛋白表达。
与阴性对照组相比,miR-146a模拟物组miR-146a的表达上调了(24.55±6.14)倍(t=-9.353,P=0.001)。与阴性对照组相比,miR-146a模拟物组IRAK-1和TRAF-6的mRNA表达分别上调了(1.16±0.10)倍(t=2.701,P=0.054)和(1.19±0.16)倍(t=2.032,P=0.112),但IRAK-1和TRAF-6的蛋白水平分别降低了73.0%(t=-9.353,P=0.001)和64.1%(t=-6.839,P=0.002)。
miR-146a模拟物成功转染至肺泡巨噬细胞NR8383。肺泡巨噬细胞中miR-146a的过表达可在蛋白质翻译水平下调IRAK-1和TRAF-6的表达,其机制可能与抑制蛋白质翻译有关。